By recognizing that our infrastructure must always be appropriate to solve the problem at hand, we have taken a novel approach to our supply of medicines in the fragmented market of Europe. The EU is the world’s biggest trading block encompassing over 550 million people, 27 countries and over 20% of world’s GDP. Whilst each market is very different, over the last decade the regulatory procedures required to gain approval to sell pharmaceuticals in the region have been harmonized.
The typical supply lead time from API order to provision of final goods can take over 6 months. Given the many supply shortages that currently exist in the region, it is common for demand to fluctuate on a regular basis. It is difficult to adapt to this using a ´make to order´ supply scheme. Instead of using a dedicated facility at Haverhill, Cambridgeshire, UK, Accord employs a state of the art ´pack to order´ or postponement strategy.
We manage to get supplies of large batches of common pharmaceutical products from various EMA and FDA approved facilities and then transfer as nude or undifferentiated products to our packing site. This bulk product is then held ready to pack, as per the requirement, to go to any of the 27 markets.